Variable-Hour Employee Benefits Eligibility Under COVID-19

The scheduling modifications employers have made in response to COVID may have unintentional consequences for the employees’ group health plan eligibility for both the remainder of the current year.

Read More

FDA Approves First COVID-19 Drug: Antiviral Remdesivir

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.

Read More

PwC: Mental Health, Telehealth Sectors Spur Robust Deal Activity Despite COVID-19

Even though the COVID-19 pandemic continues to roil the healthcare landscape financially, mergers and acquisitions remain robust thanks to heavy interest in the mental health and telehealth sectors, one expert says.

Read More

Verily’s COVID Testing Program Halted in San Francisco and Oakland

Amid fanfare in March, California officials celebrated the launch of a multimillion-dollar contract with Verily — Google’s health-focused sister company — that they said would vastly expand COVID testing among the state’s impoverished and underserved communities.

Read More

Déjà Vu for California Voters on Dialysis

The survival of California’s dialysis clinics is in the hands of its voters this November. Sound familiar?

Read More

How California Turned The Corner On COVID-19

While COVID-19 infections spike uncontrollably across the country, California has turned the corner.

Read More

With Wildfires Burning And Covid-19 Spreading, Can California Afford Stem Cell Research? Voters Are Set To Decide

This Election Day, California voters are being asked to replenish funding for the state’s ambitious stem cell research program, with a well-financed campaign that’s making heady promises about curing diabetes, paralysis, cancer, and Parkinson’s and Alzheimer’s diseases.

Read More

Trump Admin Updates Reporting Requirements, Grows Eligibility For Provider Relief Funds

The Trump administration has updated its reporting requirements for COVID-19 provider relief funds following pushback.

Read More

Telemedicine or In-Person Visit? Pros and Cons

As COVID-19 took hold in March, U.S. doctors limited in-person appointments — and many patients avoided them — for fear of infection. The result was a huge increase in the volume of remote medical and behavioral health visits.

Read More

Insurers Taking ‘Wait And See’ Approach To COVID-19 In 2021 ACA Exchange Rates: Experts

Most insurers on the Affordable Care Act’s (ACA's) insurance exchanges aren’t factoring COVID-19 into their 2021 rates or believe the pandemic will have a negligible effect, according to several experts.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square